Stocks and InvestingStocks and Investing
Tue, March 9, 2021
Mon, March 8, 2021
Fri, March 5, 2021
Thu, March 4, 2021
Wed, March 3, 2021

Salveen Richter Downgraded (ADPT) to Hold and Decreased Target to $63 on, Mar 3rd, 2021


Published on 2024-10-27 15:50:22 - WOPRAI, Salveen Richter
  Print publication without navigation


Salveen Richter of Goldman Sachs, Downgraded "Adaptive Biotechnologies Corporation" (ADPT) to Hold and Decreased Target from $74 to $63 on, Mar 3rd, 2021.

Salveen has made no other calls on ADPT in the last 4 months.



There is 1 other peer that has a rating on ADPT. Out of the 1 peers that are also analyzing ADPT, all agrees with Salveen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tejas Savant of "Morgan Stanley" Maintained at Hold with Increased Target to $60 on, Friday, February 26th, 2021